trending Market Intelligence /marketintelligence/en/news-insights/trending/233bsuk-snmgle93bqbqcg2 content esgSubNav
In This List

Zafgen closes $69M common stock offering

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Zafgen closes $69M common stock offering

Zafgen Inc., a health care delivery and management company, closed its underwritten public offering of 9.2 million of its common shares at $7.50 apiece for gross proceeds of $69.0 million.

The shares sold included 1.2 million common shares sold pursuant to the full exercise of the underwriters' overallotment option.

All of the shares in the offering were sold by the Boston-based biotechnology company.

Cowen and Co. LLC and Piper Jaffray & Co. served as joint book-running managers and JMP Securities LLC and Wedbush Securities Inc. served as co-lead managers for the offering.

Zafgen develops therapies to treat metabolically related disorders.